Tivozanib is indicated for the treatment of adult patients with relapsed or refractory advanced renal cell carcinoma (RCC) following two or more prior systemic therapies.
from FDA,2021.03
Health Information You Must Tell Your Doctor Before Taking TivozanibBefore start···【more】
Release date:2026-05-27Recommended:70
What is Tivozanib?Tivozanib (generic name: tivozanib) is a prescription medicine···【more】
Release date:2026-05-27Recommended:67
Recurrent or refractory advanced renal cell carcinoma (RCC) after two or more pr···【more】
Release date:2026-01-05Recommended:68